HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1450184Generated: October 26, 2026
Sodium hydride → 11-[4-(2-Cyanobenzyl)-1-piperazinyl]dibenz[b,f][1,4]oxazepine
https://huagongshe.com/reaction/1450184
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 2-(Bromomethyl)benzonitrile | HCID 89599 | — |
| Reactant | 11-(Piperazin-1-yl)dibenzo(b,f)(1,4)oxazepine | HCID 7061874 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 11-[4-(2-Cyanobenzyl)-1-piperazinyl]dibenz[b,f][1,4]oxazepine | HCID 18971342 | — |
Reaction Steps
To a stirred solution of 11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine (2.79 g, 10.0 mmol) (prepared from 10,11-dihydrodebenz[b,f][1,4]oxazepine-11-one, Aldrich and piperazine, as in example 1) in DMF (25 mL) was added sodium hydride (0.56 g, 60% in oil, 14 mmol) at 0° C. under argon. The mixture was stirred at 0° C. for 10 minutes at room temperature for 20 minutes, and then treated with α-bromo-o-tolunitrile (2.35 g, 12.0 mmol, Aldrich). The resulting mixture was stirred at room temperature overnight and quenched with saturated ammonium chloride solution (25 mL). The mixture was separated and extracted with ethyl acetate (3×50 mL). The combined organic phase was dried over magnesium sulfate and filtered. The filtrate was concentrated in vacuo to dryness and the residue was subjected to column chromatography using ethyl acetate:hexane (1:2) as the eluent. The title compound was obtained as a white solid (2.34 g, 59%), m.p. 136°-138° C.; MS 395 (M+ +1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05602120 |
|---|
| Source dataset | uspto-grants-1997_02 |
|---|
| ORD ID | ord-f0875813a71c4db8a298e0f89d0c3e74 |
|---|
| Source note | uspto-grants-1997_02 |
|---|